Synowledge Launches New Website

( Stamford, CT, February 22, 2010 Synowledge, LLC, a market leader in pharmacovigilance and IT services for biotechnology, pharmaceutical and manufacturing companies, announced the launch of its new website, With two distinct areas providing comprehensive coverage of the Synowledge drug safety and IT service lines, the refreshed website will serve as an important resource for customers and professionals seeking in-depth and relevant information for their respective industry.

Highlighting Synowledge‘s rapid global expansion in 2010 (link to expansion press release?); the launch of serves as the capstone to a year of record growth in new business wins and corporate development. As it further evolves, the web presence will act as a significant touch-point for key growth areas in the EMEA, APAC and Latin American regions.

“Without a doubt, in today‘s business landscape, a company is only as credible as its digital presence provides for,” said David Ingraham, Director of Sales & Marketing. “Our new online home,, aims to provide immediate credibility by making itself an invaluable location and resource for our customers and prospective clients. We think we have achieved this with a clean, intuitive and professional aesthetic, to present an in-depth look at our comprehensive service portfolio.”

About Synowledge

Founded in 2006, Synowledge is a global provider of two distinct service lines: pharmacovigilance services for pharmaceutical and biotechnology companies and IT solutions for small, mid and large size manufacturers. With more than 15 years of industry experience, our core team members have worked with leading pharmaceutical, biotech, medical device and health provider organizations, in addition to a range of global and Fortune 500 manufacturers. Our comprehensive outsourcing solutions combine the unique strengths of both onshore and offshore services to meet all of our clients‘ pressing needs. Synowledge is headquartered in Stamford CT, USA with operational facilities across the United Kingdom, Columbus, Ohio, and Bangalore, India.

Comments are closed.